Post an enquiryEnquiries on WhatsApp
Post an enquiryPost an Enquiry
Romania Flag
Tender// Various Finished Dosage Formulations needed in Romania [ENA15501]
Spitalul Clinic C.F. Timisoara is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 9-Dec-2022.
1. Famotidine (20 mg) Injections. The required quantity is 30,000 units.
2. Ondansetron (8 mg) Film coated Tablets. The required quantity is 3,000 units.
3. Lornoxicam (8 mg) Injections. The required quantity is 3,000 units.
4. Gliclazide (60 mg) Tablets. The required quantity is 5,000 units.
08 Nov 2022

Chat Comment (4)

Reply text-arrow

Croatia Flag
Tender// Various Finished Dosage Formulations needed in Croatia [ENA15076]
Psychiatrijska Bolnica Ugljan is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 25-Oct-2022.
1. Pantoprazole (20 mg) Gastro-Resistant Tablets. The required quantity is 18,000 units.
2. Lansoprazole (15 mg) Gastro-resistant Capsules. The required quantity is 2,500 units.
3. Gliclazide (60 mg) Prolonged-release Tablets. The required quantity is 4,500 units.
4. Vildagliptin (50 mg) Tablets. The required quantity is 1,500 units.
20 Sep 2022

Chat Comment (2)

Reply text-arrow

VietNam Flag
Various Finished Dosage Formulations needed in Vietnam [ENA12417]
A company that deals in the distribution of a wide range of products in allopathic formulations, herbal formulations, nutraceuticals, vaccines and orthopedic implants is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The required quantity is 500,000 units for each.
1. Fusidic Acid (2%) + Hydrocortisone (1%) Creams
2. Ganciclovir (500 mg) Injections or Infusions
3. Gefitinib (250 mg) Tablets
4. Gliclazide (80 mg) + Metformin (500 mg) Tablets
5. Glimepiride (1 mg & 2 mg)+ metformin (500 mg) Tablets
15 Jan 2022

Chat Comment (7)

Reply text-arrow

Latvia Flag
Tender// Various Finished Dosage Formulations needed in Latvia [ENA10993]
SIA “Riga East Clinical University Hospital” is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 16-Aug-2021.
1. Famotidine (20 mg) Powder and Solvent for Solution for Injection. The required quantity is 52,000 units.
2. Omeprazole (20 mg) Acid Resistant Capsules. The required quantity is 870,000 units.
3. Pantoprazole (40 mg) Powder for Solution for Infusion. The required quantity is 91,000 units.
4. Esomeprazole (20 mg) Enteric-Coated Tablets or Capsules. The required quantity is 10,000 units.
5. Atropine Sulfate (1 mg / ml) Solution for Injection. The required quantity is 25,000 units.
6. Metoclopramide (10 mg) Tablets. The required quantity is 35,000 units.
7. Metoclopramide (10 mg / 2 ml) Solution for Injection. The required quantity is 117,600 units.
8. Ondansetron (8 mg) Tablets or Film-Coated Tablets. The required quantity is 5,000 units.
9. Bisacodyl (10 mg) Suppositories. The required quantity is 25,000 units.
10. Sulfasalazine (500 mg) Enteric-Film-Coated Tablets. The required quantity is 13,000 units.
11. Racecadotril (100 mg) Hard Capsules. The required quantity is 2,100 units.
12. Metformin (500 mg) Film-Coated Tablets. The required quantity is 52,520 units.
13. Gliclazide (30 mg) Prolonged-Release Tablets. The required quantity is 4,800 units.
14. Sitagliptin (50 mg) + Metformin Hydrochloride (850 mg) Film-Coated Tablets. The required quantity is 1,400 units.
30 Jul 2021

Chat Comment (9)

Reply text-arrow

Poland Flag
Tender// Various Finished Dosage Formulations needed in Poland [ENA10922]
Specialist Hospital of Ludwik Rydygiera in Krakow limited liability company is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 20-Aug-2021.
1. Amlodipine (10 mg) Pills. The required quantity is 9,000 units.
2. Carbamazepine (200 mg) Divisible Tablets. The required quantity is 2,500 units.
3. Carvedilol (6.25 mg) Pills. The required quantity is 9,000 units.
4. Methylprednisolone (4 mg & 10 mg) Pills. The required quantity is 4,500 units & 7,500 units respectively.
5. Pantoprazole (40 mg) Gastro-Resistant Tablets. The required quantity is 2,800 units.
6. Spironolactone (25 mg) Pills. The required quantity is 20,000 units.
7. Bupivacaine (50 mg/ 10 ml) Solution for Injection. The required quantity is 4,000 units.
8. Rivaroxaban (15 mg) Coated Tablets. The required quantity is 7,000 units.
9. Gliclazide (60 mg) Oral Prolonged Release Tablets. The required quantity is 7,200 units.
10. Indapamide (1.5 mg) Oral Prolonged Release Tablets. The required quantity is 16,200 units.
11. Perindoprilum (5 mg) Coated Tablets. The required quantity is 9,000 units.
12. Aciclovir (250 mg) Vials. The required quantity is 1,500 units.
13. Hydrocortisone (100 mg) Ampoules/ Vials. The required quantity is 6,000 units.
21 Jul 2021

Chat Comment (3)

Reply text-arrow

Bulgaria Flag
Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA10834]
Glavna direktsiya "Izpalnenie na nakazaniyata" is looking for supplies of Various Finished Dosage Formulations. The deadline is 04-Aug-2021.
1. Gentamicin (80 mg / 2 ml) Ampoules. The required quantity is 2,020 units.
2. Gliclazide (60 mg) Tablets. The required quantity is 7,210 units.
3. Glyceryl Trinitrate (5 mg) Tablets. The required quantity is 1,830 units.
4. Hydrochlorothiazide (25 mg) Tablets. The required quantity is 10,120 units.
5. Bisoprolol (10 mg) Tablets. The required quantity is 7,390 units.
6. Azithromycin (500 mg) Tablets. The required quantity is 2,625 units.
7. Atorvastatin (20 mg) Tablets. The required quantity is 6,880 units.
8. Atenolol (25 mg) Tablets. The required quantity is 2,700 units.
9. Amoxicillin (1000 mg) Film-coated Tablets. The required quantity is 27,180 units.
10. Amlodipine (10 mg) Tablets. The required quantity is 20,400 units.
11. Allopurinol (100 mg) Tablets. The required quantity is 4,740 units.
12. Ascorbic Acid (1000 mg) Effervescent Tablets. The required quantity is 1,500 units.
13. Carbamazepine (300 mg) Tablets. The required quantity is 9,300 units.
14. Carvedilol (6.25 mg) Tablets. The required quantity is 1,370 units.
10 Jul 2021

Chat Comment (7)

Reply text-arrow

VietNam Flag
Various Finished Dosage Formulations needed in Vietnam [ENA10193]
A company that is a leading provider of regulatory compliance products and services for the life sciences industry is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The required quantity is MOQ for each. The suppliers must support this enquiry with EU CTD Dossier.
1. Gliclazide (30 mg & 60 mg) Extended-release Tablets
2. Metformin (500 mg & 850 mg) Film-coated Tablets
3. Esomeprazole (40 mg) Enteric Coated Tablets
4. Esomeprazole (20 mg) Film-Coated Tablets
5. Lansoprazole (30 mg) Pellet Enteric Coated Capsules
6. Pantoprazole (20 mg & 40 mg) Enteric Coated Tablets
7. Rosuvastatin (10 mg, 5 mg & 20 mg) Film-Coated Tablets
8. Azithromycin (500 mg) Tablets
9. Clarithromycin (500 mg & 250 mg) Tablets
10. Alfuzosin (10 mg) Extended-Release Tablets
12 Apr 2021

Chat Comment (7)

Reply text-arrow

Poland Flag
Tender// Various Finished Dosage Formulations needed in Poland [ENA10012]
Szpital Lipno Sp. z o.o. is looking for supplies of Various Finished Dosage Formulations. The deadline is 31-March-2021.
1. Drotaverine (40 mg) Tablets. The required quantity is 5,300 units.
2. Drotaverine (40 mg/ 2 ml) Solution for Shock. The required quantity is 2,400 units.
3. Loperamide (2 mg) Tablets. The required quantity is 3,900 units.
4. Mebeverine (135 mg) Tablets. The required quantity is 240 units.
5. Acarbose (50 mg) Tablets. The required quantity is 750 units.
6. Empagliflozin (10 mg) Tablets. The required quantity is 750 units.
7. Gliclazide (60 mg) Tablets with Prolonged Release. The required quantity is 2,484 units.
8. Metformin (850 mg, 1000 mg and 500 mg) Tablets. The required quantity is 4,950 units, 5,160 units and 6,570 units respectively.
9. Potassium Chloride (391 mg) Tablets with Prolonged Release. The required quantity is 25,920 units.
10. Thiamine (25 mg) Tablets. The required quantity is 31,500 units.
22 Mar 2021

Chat Comment (2)

Reply text-arrow

VietNam Flag
Gliclazide (30 mg & 60 mg) Tablets needed in Vietnam [ENA07620]
Saifen Drugs, a global marketing company is looking for suppliers of Gliclazide (30 mg & 60 mg) Tablets. The suppliers must support this enquiry with EU GMP & ACTD dossier. Interested suppliers can contact them via their email: sourcinghead@saifendrugs.com.
18 Jun 2020

Chat Comment (2)

Reply text-arrow

Belarus Flag
Various Finished Dosage Formulations needed in Belarus [ENA07515]
A company that deals in the development, production and sale of medicines, dietary supplements, as well as medical devices is looking for suppliers of Various Finished Dosage Formulations. The suppliers must support this enquiry with EU-CTD Dossier with BE/CT as applicable and PIC/s or EU GMP or USFDA.
1. Ramipril (1.25 mg, 2.50 mg, 5 mg & 10 mg) Tablets (Quantity: 200,000 units/annum, 300,000 units/annum, 400,000 units/annum & 300,000 units/annum respectively)
2. Tamsulosin 0.4 mg Capsules (Quantity: 500,000 units/annum)
3. Choline Alfoscerate 400 mg Softgel Capsules (Quantity: 1,000,000 units/annum)
4. Bisoprolol (2.5 mg, 5 mg & 10 mg) Tablets (Quantity: 300,000 units/annum, 400,000 units/annum, & 400,000 units/annum respectively)
5. Lisinopril (5 mg, 10 mg & 20 mg) Tablets (Quantity: 300 000 units/annum, 800,000 units/annum, 500,000 units/annum respectively)
6. Metformin (500 mg, 850 mg & 1000 mg) Tablets (Quantity: 300,000 units/annum, 500,000 units/annum & 1,000,000 units/annum respectively)
7. Linezolide 600 mg Tablets (Quantity: 500,000 units/year)
8. Gliclazide MR (30 mg & 60 mg) Tablets (Quantity: 3,000,000 units/annum & 2,000,000 units/annum respectively)
09 Jun 2020

Chat Comment (8)

Reply text-arrow

Belarus Flag
Various Finished Dosage Formulations needed in Belarus [ENA07488]
Nika Pharmaceuticals, a company that deals in the development, production and sale of medicines, dietary supplements, as well as medical devices is looking for suppliers of Various Finished Dosage Formulations. The suppliers must support this enquiry with EU-CTD Dossiers with PIC/s approved plant. The fina market is Russia & Belarus Interested suppliers can contact them via their email id: kgpsundaram@kgplabs.com.
1. Gliclazide (30 mg & 60 mg) MR Tablet
2. Cefuroxime (125 mg/5ml in 100 ml) Oral Suspension. The required quantity is 300,000 units/annum
3. Ibuprofen (100 mg/5ml & 200 mg/5ml) Oral Suspension or children. The required quantity is 300,000 units/annum.
05 Jun 2020

Chat Comment (3)

Reply text-arrow

SaudiArabia Flag
Various EUCTD/CTD dossiers needed in Saudi Arabia [ENA06197]
A company with over 25 years of expertise in biopharmaceuticals with cutting edge medicine-knowledge and technology is looking for EUCTD/CTD dossiers for various formulations. All the formulations will be according to RLD standards.
1. Acetazolamide
2. Acetylsalicylic Acid
3. Amiodarone
4. Atropine
5. Busulfan
6. Caffeine
7. Calcitriol
8. Chlorhexidine
9. Colchicine
10. Colestyramine
11. Diltiazem
12. Dobutamine
13. Ethinylestradiol
14. Furosemide
15. Gliclazide
16. Granisetron
17. Haloperidol
18. Hydralazine
19. Hydroxycarbamide
20. Hydroxyzine
21. Isoniazid
22. Ketoprofen
23. Lidocaine
24. Methotrexate
25. Miconazole
26. Midodrine
27. Nifedipine
28. Nitrofurantoin
29. Penicillamine
30. Pentoxifylline
31. Piperacillin
32. Propylthiouracil
33. Ranitidine
34. Risperidone
35. Salbutamol
36. Simethicone
37. Temozolomide
38. Tranexamic Acid
39. Tropicamide
40. Vancomycin
41. Vigabatrin
42. Warfarin
02 Jan 2020

Chat Comment (18)

Reply text-arrow

Brazil Flag
Tender// various finished formulations needed in Brazil [ENA05113]
A leading pharmaceutical trading company in the Netherland is looking for suppliers of various finished formulations for tender in Brazil. The required packing size is (2x15). The dosage strength and volume forecast is mentioned below.
1. Ursodeoxycholic acid (150 mg) tablets - 976,270 units
2. Ursodeoxycholic acid (300 mg) tablets - 2,921,330 units
3. Amiodarone (300 mg) tablets - 8,451,600 units
4. Carvedilol (3.125 mg) tablets - 40,000,000 units
5. Carvedilol (6.25 mg) tablets - 60,000,000 units
6. Carvedilol (12.5 mg) tablets - 70,000,000 units
7. Carvedilol (25 mg) tablets - 30,000,000 units
8. Clarithromycin (500 mg) tablets - 469,100 units
9. Finasteride (5 mg) tablets - 1,246,600 units
10. Gliclazide (30 mg) tablets - 100,000,000 units
11. Gliclazide (60 mg) tablets - 80,000,000 units
12. Levothyroxine (25 mg) tablets - 34,000,000 units
13. Levothyroxine (50 mg) tablets - 39,200,000 units
14. Levothyroxine (100 mg) tablets - 25,000,00 units
15. Sertraline (50 mg) tablets - 90,000,000 units
16. Venlafaxine (37.5 mg) capsules - 3,000,000 units
17. Venlafaxine (75 mg) capsules - 21,000,000 units
18. Venlafaxine (150 mg) tablets - 6,000,000 units.
10 Sep 2019

Chat Comment (10)

Reply text-arrow

Malaysia Flag
Various finished formulations needed in Malaysia [ENA04895]
A Malaysian company is looking for suppliers for various finished formulations mentioned below. The Supplier must support this enquiry with GMP from any PIC/S authorities, CTD dossier and Stability Data Zone 4b.
1. Gabapentin 300mg Tablet
2. Gliclazide 80mg Tablet
3. Glyceryl Trinitrate Sublingual 500mcg Tablet
4. Haloperidol 5mg Tablet
5. Isosorbide-5-mononitrate 20mg & 40mg Tablet
6. Loperamide 2mg Tablet
7. Loratadine 10mg Tablet
8. Losartan 100mg & 50mg Tablet
15 Aug 2019

Chat Comment (12)

Reply text-arrow

saudiarabiapng-1555324364png-1605701218 Flag
Gliclazide eCTD dossier needed in the United Arab Emirates [ENA04284]
A GMP certified company offering development, manufacturing and marketing of branded generic pharmaceutical products is looking for suppliers of Gliclazide (60 mg) modified-release eCTD dossier.
28 May 2019

Chat Comment (10)

Reply text-arrow

Market Place
Enquiry// Metformin and Gliclazide tablets needed for the UK market [ENA00621]
A leading pharmaceutical wholesaler serving the pharmaceutical and healthcare industries in the UK and throughout the world is looking for suppliers/manufacturers for following products for distribution in the UK market:
1. Metformin IR Tablets 500 mg/850 mg/1000 mg
2. Metformin XL Tablets 500 mg/750 mg/1000 mg
3. Gliclazide 40 mg/80 mg
4. Gliclazide SR 30 mg/60 mg
21 Dec 2017

Chat Comment (2)

Reply text-arrow

Market Place
Enquiry// Rituximab, Trastuzumab and various other products needed in Philippines and Vietnam [ENA00506]
Corex Trade Links Inc. a company committed to distributing, products of stringent quality, specifications conforming to international pharmaceutical standards is searching for EU GMP manufacturers to supply following products:
1. Rituximab
2. Trastuzumab
3. Doxorubicin Liposomal
4. Esomeprazole Lyophilised Injection
5. Tigecycline Lyophilized
6. Gliclazide + Metformin
Interested suppliers/manufacturers should contact Rahul R Shah via Email: info@corexbiopharm.com or Tel: +84907500805.
04 Oct 2017

Chat Comment (1)

Reply text-arrow

Market Place
Enquiry// Looking for Marketing Partners for various Finished Dose Formulations in China [ENA00365]
Inventia Healthcare, one of the leading drug delivery companies in India is searching for partners for its US FILED Products for the Chinese Market:

Products developed against international innovator:
1. Gliclazide 30/60 mg ER Tablets
2. Metformin HCl 500/750/1000 mg SR Tablets.
3. Lansoprazole 15/30 mg EC Capsules
4. Metoprolol 25/50/100/200 mg ER Tablets
5. Olmesartan Medoxomil 5/20/40 mg Tablets
6. Telmisartan 20/40/80 mg Tablets
7. Telmisartan + Hydrochlorthiazide 40/12.5, 80/12.5, 80/25 mg Tablets
8. Duloxetine 20/30/60 mg DR Capsules
9. Venlafaxine 37.5/75/150 mg SR Capsules
10. Darifenacin Hydrobromide 7.5/15 mg ER Tablets
11. Felodipine 2.5/5/10 mg ER Tablets
12. Rosuvastatin 5 /10/20/40 mg Tablets
13. Iloperidone 1/2/4/6/8/10/12 mg Tablets
14. Paliperidone 1.5/3/6/9 mg ER Tablets
15. Tolterodine Tartrate 2/4 mg ER Capsules

New Products Under development
1. Sitagliptin + Metformin 50/500 mg, 50/1000 mg Tablets
2. Sitagliptin + Metformin ER 50/500 mg, 50/1000; 100/1000 mg Tablets
3. Dapagliflozin 5/10 mg Tablets
4. Mesalamine 1.2 mg DR Tablets
5. Ezetimibe 10 mg Tablets
Interested partners can contact Sumeet Mehta at sumeet.mehta@inventiahealthcare.com or call +91-9930922062.
12 Jun 2017

Comment Comment

Reply text-arrow

Market Place
Enquiry// Looking for Marketing Partners for various Finished Dose Formulations across Emerging Markets [ENA00236...
Inventia Healthcare, is searching for partners for:
DEVELOPED PRODUCTS
South East Asia, CIS, Australia, Middle East & Africa, LATAM:-
1. Lansoprazole 15/30 mg EC Capsules
2. Metoprolol 25/50/100/200 mg ER Tablets
3. Olmesartan Medoxomil 5, 20, 40 mg Tablets
4. Telmisartan 20/40/80 mg Tablets
5. Telmisartan + Hydrochlorthiazide 40/12.5, 80/12.5, 80/25 mg Tablets
6. Duloxetine 20/30/60 mg DR Capsules
7. Venlafaxine 37.5/75/150 mg SR Capsules
8. Darifenacin Hydrobromide 7.5/15 mg ER Tablets

South East Asia, CIS, Australia, Middle East & Africa, LATAM Argentina, Uruguay, Paraguay, Chile:-
1. Metformin HCl 750 mg SR Tablets

South East Asia, CIS, Australia, Middle East & Africa, LATAM, India:-
1. Gliclazide 30/60 mg ER Tablets
2. Felodipine 2.5/5/10 mg ER Tablets
3. Rosuvastatin 5 /10 /20/40 mg Tablets

Dossier for South East Asia, CIS, Australia Korea, Taiwan, China, Russia, Ukraine, Kazakhstan, Uzbekistan, Hong Kong, Thailand, Middle East & Africa, South Africa, GCC, Iraq, Algeria, LATAM, Argentina, Uruguay, Paraguay, Chile, India:-
1. Metformin HCl 500 mg SR Tablets

Dossier for South East Asia, CIS, Australia, Korea, Taiwan, China, Russia, Ukraine, Kazakhstan, Uzbekistan, Hong Kong, Thailand, Malaysia, LATAM, Argentina, Uruguay, Paraguay, Chile, All countries in SEA, CIS, Australia, Middle East & Africa:-
1. Metformin HCl 1000 mg SR Tablets
Interested partners can contact @ https://www.pharmacompass.com/api-manufacturers/inventia-healthcare-private-limited
02 Mar 2017

Chat Comment (1)

Reply text-arrow

Market Place
Enquiry// Various Pharmaceutical dossiers needed for registration in Guyana [ENA00213]
Pharma-X Consultancy Ltd (UK) is looking for Pharmaceutical Dossiers and sample products to facilitate registeration of below mentioned Products in Guyana:
1. Atorvastatin 20mg Tablets 28S
2. Gliclazide 80mg Tablets 28S
3. Ramipril 5mg Capsules 28S
4. Ramipril 10mg Capsules 28S
5. Atenolol 50mg Tablets 28S
6. Simvastatin 20mg Tablets 28S
7. Amlodipine 10mg Tablets 28S
8. Levothyroxine 100mcg Tablets 28S
9. Metformin 500mg Tablets 84S
10. Metformin 500mg Tablets 84S
11. Levothyroxine 50mcg Tablets 28S
12. Clopidogrel 75mg Tablets 28S/30S
13. Atorvastatin 40mg Tablets 28S
14. Codeine 30mg Tablets 28S
15. Amlodipine 5mg Tablets 28S
16. Co-Amoxiclav 625mg Tablets 21S
17. Atorvastatin 10mg Tablets 28S
18. Losartan 50mg Tablets 28S
19. Ciprofloxacin 500mg Tablets 20S
20. Spironolactone 25mg Tablets 28S
Interested suppliers can contact Ian Dhanraj via Email: pharmaxconsultanctltd@yahoo.co.uk or Tel: +44 (0) 7716202644.
14 Feb 2017

Chat Comment (1)

Reply text-arrow

Market Place
EU CTD Dossiers Available // Looking for Marketing Partners in the EU for various products [ENA00142]
Inventia Healthcare, one of the leading drug delivery companies in India is searching for partners in Europe for the following products which are at various stages of development -

Approved MA:
1. Duloxetine DR Capsules 30 mg/ 60 mg

Products Under development:
1. Gliclazide MR Tablets 30 mg/ 60 mg - EU fillable dossier will be ready by Oct 2017
2. Ezetimibe 10 mg Tablets - EU fillable dossier will be ready by Dec 2017

Products developed against international innovators and easily extendable to EU
1. Metformin SR Tablets 500 mg
2. Metformin SR Tablets 750 mg
3. Metformin SR Tablets 1000 mg
4. Darifenacin ER tablets 7.5 mg/ 15 mg

New Products Under development for EU
1. Rivaroxaban Tablets 10mg, 15 mg, 20 mg: will be ready by Q3 2019
2. Sitagliptin + Metformin: Target to be ready by Q2 2022
3. Mesalamine 1200 Gm Tablets - Target to be ready by Q3 2019

Interested partners should contact Priyanka Dhanjal at priyanka.dhanjal@inventiahealthcare.com or call +919987152274
02 Jan 2017

Chat Comment (1)

Reply text-arrow

Market Place
In-Licensing & Supply Request // Anti-diabetic products (Metformin, Gliclazide etc.) wanted for the U.K. [ENA0002...
A market leader in the sales of glucose monitors, in the United Kingdom, is looking to expand its product offering to include anti-diabetic medicines. They are urgently seeking partners who can provide products which are approved/approvable by the MHRA
15 Jun 2016

Chat Comment (2)

Reply text-arrow

Market Place
In-Licensing Opportunity// Partners needed for Oral Dosage Forms of Mebeverine, Memantine, Metformin & Glicazide ...
A Switzerland-based, international company, focused on marketing products in Eastern Europe and CIS countries is interested in finding partners for Mebeverine Hydrochloride (135 MG Tablets), Memantine Hydrochloride (5 and 10 MG Film Coated Tablets), Metformin Hydrochloride (500 MG Prolonged Tablets), Gliclazide (60 MG Tablets).
28 Jan 2016

Chat Comment (8)

Reply text-arrow